Management of coronary artery aneurysms

A Kawsara, IJ Núñez Gil, F Alqahtani… - JACC: Cardiovascular …, 2018 - jacc.org
Aneurysmal dilation of coronary arteries is observed in up to 5% of patients undergoing
coronary angiography. Due to their poorly elucidated underlying mechanisms, their variable …

[HTML][HTML] Coronary artery aneurysms: a review of the epidemiology, pathophysiology, diagnosis, and treatment

S Abou Sherif, O Ozden Tok, Ö Taşköylü… - Frontiers in …, 2017 - frontiersin.org
Coronary artery aneurysms (CAAs) are uncommon and describe a localized dilatation of a
coronary artery segment more than 1.5-fold compared with adjacent normal segments. The …

Coronary stents: current status

S Garg, PW Serruys - Journal of the American College of Cardiology, 2010 - jacc.org
Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

[HTML][HTML] Giant coronary aneurysms, from diagnosis to treatment: a literature review

V Pham, Q De Hemptinne, JM Grinda, D Duboc… - Archives of …, 2020 - Elsevier
Coronary aneurysms are classically defined as a segment of the artery in which dilation
exceeds the diameter of an adjacent portion (considered as a reference point) by more than …

[HTML][HTML] Coronary artery aneurysm: evaluation, prognosis, and proposed treatment strategies

AS Sheikh, A Hailan, T Kinnaird, A Choudhury… - Heart …, 2019 - journals.lww.com
Coronary artery aneurysm is a rare disorder, which occurs in 0.3%–4.9% of patients
undergoing coronary angiography. Atherosclerosis accounts for> 90% of coronary artery …

Giant coronary artery aneurysms: review and update

PD Crawley, WJ Mahlow… - Texas Heart …, 2014 - meridian.allenpress.com
Giant coronary artery aneurysms are rare, with a reported prevalence of 0.02% to 0.2%.
Causative factors include atherosclerosis, Takayasu arteritis, congenital disorders …

Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings

F Alfonso, MJ Pérez-Vizcayno, M Ruiz, A Suárez… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to assess clinical, angiographic, and intravascular ultrasound
(IVUS) findings in patients developing coronary aneurysms (CANs) after drug-eluting stent …

1-year all-comers analysis of the Eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty

T Bisdas, E Beropoulis, A Argyriou, G Torsello… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of this study was to assess the performance of the fluoropolymer-based
paclitaxel-eluting stent (PES) in long femoropopliteal lesions. Background: The new …

[HTML][HTML] Aneurysmal coronary artery disease: an overview

MS ElGuindy, AM ElGuindy - Global Cardiology Science & Practice, 2017 - ncbi.nlm.nih.gov
Aneurysmal coronary artery disease (ACAD) comprises both coronary artery aneurysms
(CAA) and coronary artery ectasia (CAE). The reported prevalence of ACAD varies widely …

[HTML][HTML] Treatment and outcome of patients with coronary artery ectasia: current evidence and novel opportunities for an old dilemma

L Esposito, M Di Maio, A Silverio, FP Cancro… - Frontiers in …, 2022 - frontiersin.org
Coronary artery ectasia (CAE) is defined as a diffuse or focal dilation of an epicardial
coronary artery, which diameter exceeds by at least 1. 5 times the normal adjacent segment …